Hydroxysteroid sulfotransferase 2B1 affects gastric epithelial function and carcinogenesis induced by a carcinogenic agent

Lipids Health Dis. 2019 Nov 22;18(1):203. doi: 10.1186/s12944-019-1149-6.

Abstract

Background: A healthy gastric mucosal epithelium exhibits tumor-suppressive properties. Gastric epithelial cell dysfunction contributes to gastric cancer development. Oxysterols provided from food or cholesterol oxidation in the gastric epithelium may be further sulfated by hydroxysteroid sulfotransferase 2B1 (SULT2B1), which is highly abundant in the gastric epithelium. However, the effects of SULT2B1 on gastric epithelial function and gastric carcinogenesis are unclear.

Methods: A mouse gastric tumor model was established using carcinogenic agent 3-methylcholanthrene (3-MCA). A SULT2B1 deletion (SULT2B1-/-) human gastric epithelial line GES-1 was constructed by CRISPR/CAS9 genome editing system.

Results: The gastric tumor incidence was higher in the SULT2B1-/- mice than in the wild-type (WT) mice. In gastric epithelial cells, adenovirus-mediated SULT2B1b overexpression reduced the levels of oxysterols, such as 24(R/S),25-epoxycholesterol (24(R/S),25-EC) and 27-hydroxycholesterol (27HC). This condition also increased PI3K/AKT signaling to promote gastric epithelial cell proliferation, epithelization, and epithelial development. However, SULT2B1 deletion or SULT2B1 knockdown suppressed PI3K/AKT signaling, epithelial cell epithelization, and wound healing and induced gastric epithelial cell malignant transition upon 3-MCA induction.

Conclusions: The abundant SULT2B1 expression in normal gastric epithelium might maintain epithelial function via the PI3K/AKT signaling pathway and suppress gastric carcinogenesis induced by a carcinogenic agent.

Keywords: Gastric carcinogenesis; Gastric epithelial cell; Hydroxysteroid Sulfotransferase 2B1 (SULT2B1); Oxysterol; PI3K/AKT signaling.

MeSH terms

  • Animals
  • Base Sequence
  • CRISPR-Cas Systems
  • Carcinogenesis / drug effects
  • Carcinogenesis / genetics*
  • Carcinogenesis / metabolism
  • Carcinogenesis / pathology
  • Cell Line, Tumor
  • Cell Proliferation
  • Cholesterol / analogs & derivatives
  • Cholesterol / metabolism
  • Gastric Mucosa / drug effects
  • Gastric Mucosa / enzymology
  • Gastric Mucosa / pathology
  • Gene Editing
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Hydroxycholesterols / metabolism
  • Methylcholanthrene / administration & dosage
  • Mice
  • Mice, Knockout
  • Phosphatidylinositol 3-Kinases / genetics*
  • Phosphatidylinositol 3-Kinases / metabolism
  • Proto-Oncogene Proteins c-akt / genetics*
  • Proto-Oncogene Proteins c-akt / metabolism
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / metabolism
  • Signal Transduction
  • Stomach Neoplasms / chemically induced
  • Stomach Neoplasms / enzymology
  • Stomach Neoplasms / genetics*
  • Stomach Neoplasms / mortality
  • Sulfotransferases / antagonists & inhibitors
  • Sulfotransferases / deficiency
  • Sulfotransferases / genetics*
  • Survival Analysis

Substances

  • Hydroxycholesterols
  • RNA, Small Interfering
  • Methylcholanthrene
  • 24,25-epoxycholesterol
  • 27-hydroxycholesterol
  • Cholesterol
  • Proto-Oncogene Proteins c-akt
  • SULT2B1b protein, mouse
  • Sulfotransferases
  • SULT2B1 protein, human